EFS
Essex Financial Services’s iShares Biotechnology ETF IBB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $848K | Hold |
6,704
| – | – | 0.06% | 293 |
|
2025
Q1 | $857K | Sell |
6,704
-254
| -4% | -$32.5K | 0.06% | 259 |
|
2024
Q4 | $920K | Sell |
6,958
-15
| -0.2% | -$1.98K | 0.07% | 250 |
|
2024
Q3 | $1M | Sell |
6,973
-1,218
| -15% | -$175K | 0.07% | 241 |
|
2024
Q2 | $1.16M | Buy |
8,191
+1,146
| +16% | +$163K | 0.09% | 208 |
|
2024
Q1 | $967K | Buy |
7,045
+580
| +9% | +$79.6K | 0.09% | 213 |
|
2023
Q4 | $878K | Sell |
6,465
-435
| -6% | -$59.1K | 0.09% | 214 |
|
2023
Q3 | $844K | Hold |
6,900
| – | – | 0.1% | 197 |
|
2023
Q2 | $876K | Sell |
6,900
-25
| -0.4% | -$3.17K | 0.1% | 194 |
|
2023
Q1 | $894K | Sell |
6,925
-168
| -2% | -$21.7K | 0.09% | 196 |
|
2022
Q4 | $931K | Sell |
7,093
-144
| -2% | -$18.9K | 0.1% | 188 |
|
2022
Q3 | $846K | Sell |
7,237
-120
| -2% | -$14K | 0.1% | 183 |
|
2022
Q2 | $865K | Sell |
7,357
-835
| -10% | -$98.2K | 0.1% | 198 |
|
2022
Q1 | $1.07M | Buy |
8,192
+72
| +0.9% | +$9.38K | 0.1% | 193 |
|
2021
Q4 | $1.24M | Buy |
8,120
+360
| +5% | +$54.9K | 0.12% | 169 |
|
2021
Q3 | $1.26M | Buy |
7,760
+1,175
| +18% | +$190K | 0.14% | 155 |
|
2021
Q2 | $991K | Hold |
6,585
| – | – | 0.14% | 151 |
|
2021
Q1 | $991K | Buy |
6,585
+362
| +6% | +$54.5K | 0.18% | 129 |
|
2020
Q4 | $943K | Buy |
6,223
+1,541
| +33% | +$234K | 0.19% | 119 |
|
2020
Q3 | $634K | Buy |
4,682
+980
| +26% | +$133K | 0.16% | 130 |
|
2020
Q2 | $506K | Buy |
3,702
+190
| +5% | +$26K | 0.16% | 130 |
|
2020
Q1 | $378K | Buy |
3,512
+1,349
| +62% | +$145K | 0.13% | 151 |
|
2019
Q4 | $261K | Buy |
+2,163
| New | +$261K | 0.07% | 227 |
|
2018
Q2 | – | Sell |
-6,141
| Closed | -$656K | – | 305 |
|
2018
Q1 | $656K | Buy |
+6,141
| New | +$656K | 0.13% | 165 |
|
2017
Q3 | – | Sell |
-1,053
| Closed | -$327K | – | 304 |
|
2017
Q2 | $327K | Buy |
1,053
+158
| +18% | +$49.1K | 0.07% | 256 |
|
2017
Q1 | $262K | Sell |
895
-26
| -3% | -$7.61K | 0.06% | 270 |
|
2016
Q4 | $244K | Buy |
921
+153
| +20% | +$40.5K | 0.05% | 273 |
|
2016
Q3 | $222K | Buy |
+768
| New | +$222K | 0.05% | 274 |
|
2016
Q2 | – | Sell |
-1,813
| Closed | -$473K | – | 310 |
|
2016
Q1 | $473K | Sell |
1,813
-1,119
| -38% | -$292K | 0.12% | 176 |
|
2015
Q4 | $992K | Sell |
2,932
-90
| -3% | -$30.5K | 0.24% | 104 |
|
2015
Q3 | $917K | Sell |
3,022
-65
| -2% | -$19.7K | 0.24% | 102 |
|
2015
Q2 | $1.14M | Buy |
3,087
+205
| +7% | +$75.6K | 0.29% | 85 |
|
2015
Q1 | $990K | Buy |
2,882
+405
| +16% | +$139K | 0.25% | 103 |
|
2014
Q4 | $751K | Buy |
2,477
+260
| +12% | +$78.8K | 0.2% | 127 |
|
2014
Q3 | $607K | Buy |
2,217
+489
| +28% | +$134K | 0.18% | 139 |
|
2014
Q2 | $444K | Buy |
1,728
+95
| +6% | +$24.4K | 0.13% | 176 |
|
2014
Q1 | $386K | Buy |
+1,633
| New | +$386K | 0.13% | 179 |
|